Teva To Grant $15M To Brain Researchers

Israeli pharmaceutical giant Teva has announced that it will strategically focus on Israeli brain research over the next five years. The company has allocated a $15 million fund that will be granted to both researches that are near completion and ones that are in their early stages, but show potential.